Nika Pharmaceuticals Debt-to-Assets Ratio Growth & History (NIKA)

Nika Pharmaceuticals's debt-to-assets ratio was 15.18 for fiscal 2025.

View full Nika Pharmaceuticals company overview

Nika Pharmaceuticals annual debt-to-assets ratio history

Nika Pharmaceuticals annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-3115.181.84+13.80%
20242024-12-3113.348.14+156.85%
20232023-12-315.19−15.85−75.32%
20222022-12-3121.04−39.15−65.04%
20212021-12-3160.20

Nika Pharmaceuticals debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Nika Pharmaceuticals's debt-to-assets ratio decreased from 60.20 to 15.18, a change of −45.02. The latest reported quarter, Q2 2026, shows 34.26.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nika Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about NIKA yet. Start the conversation.

Write the first post